trending Market Intelligence /marketintelligence/en/news-insights/trending/KONsb7298mOz2pt3l58THw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Versartis chief development officer to leave

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Versartis chief development officer to leave

Versartis Inc. said Chief Development Officer Colin Hislop's employment will be terminated, effective Oct. 20.

Hislop joined Versartis in 2016 from Anthera Pharmaceuticals Inc., where he served as the company's chief medical officer.